Matthew M. Holub concentrates his practice on resolving intellectual property disputes, including complex patent litigation involving the Hatch-Waxman Act and Abbreviated New Drug Applications. Matt also applies his strong foundation in the pharmaceutical industry to various complex litigation matters, including both antitrust and contractual claims.
Matt is well-versed in all stages of trial practice, and has extensive experience with pleadings, electronic discovery and motion practice. His awareness that clients desire to quickly reach beneficial resolutions has made him an integral part of settlement teams that successfully resolved multimillion-dollar litigations.
Articles in the National Law Review database by Matthew M. Holub